KALA BIO, Inc. Operating Income Loss

• KALA BIO, Inc. showed a decrease of -3.3% in Operating Income Loss from 2023 to 2024.
• This data is from KALA BIO, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
• XBRL data for this metric is available from 2015 to 2024 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2015 to 2024), KALA BIO, Inc.'s Operating Income Loss has declined by 157.0%.
• Historical annual values: Fiscal year 2024: -$40.98 million | Fiscal year 2023: -$39.66 million | Fiscal year 2022: -$81.71 million | Fiscal year 2021: -$130.25 million | Fiscal year 2020: -$96.23 million | Fiscal year 2019: -$88.22 million | Fiscal year 2018: -$64.72 million | Fiscal year 2017: -$39.88 million | Fiscal year 2016: -$32.67 million | Fiscal year 2015: -$15.95 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026